Advertisement
News
Advertisement

Abbott Labs' Worcester facility to become part of spinoff

Thu, 11/29/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Abbott Laboratories’ (NYSE: ABT) board of directors has voted in favor of a planned spinoff of its pharmaceuticals business, the company said Thursday.

As of Jan. 1, 2013, the new drug division, called AbbVie, will begin trading on its own with the ticker symbol (Nasdaq: ABBV). The remainder of the company, including medical devices, diagnostics and nutritional products, will remain under the ABT ticker.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading